Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen

Lancet

Volumn 347, Issue 9007, 1996, Pages 1008-1013

  Brunner, Eric ^a   Smith, George Davey ^b   Marmot, Michael ^a   Canner, Robert ^a   Beksinska, Margaret ^a   O'Brien, John ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY HEIGHT; CHILD BEHAVIOR; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; EMPLOYMENT; FEMALE; FIBRINOGEN BLOOD LEVEL; HEALTH BEHAVIOR; HUMAN; MALE; NORMAL HUMAN; PARENT; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; SOCIAL CLASS; SOCIAL PSYCHOLOGY; SOCIAL STATUS; SOCIOECONOMICS; SOCIOLOGY; WORK CAPACITY;

EID: 0029916275     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90147-6     Document Type: Article

References (36)

1. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-79.
2. Wilhelmsen L, Svardsudd K, Korsan-Bengsten K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-05.
3. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. JAMA 1987; 258: 1183-86.
4. Yarnell JWG, Baker IA, Sweetnam PM, et al. Fibrinogen, viscosity and white blood cell counts are major risk factors for ischemic heart disease: the Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation 1991; 83: 836-44.
5. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54-59.
6. Barker DJP, Meade TW, Fall CHD, et al. Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ 1992; 304: 148-52.
7. Power C, Manor O, Fox J. Health and class: the early years. London: Chapman & Hall, 1991.
8. Markowe HLJ, Marmot MG, Shipley MJ, et al. Fibrinogen: a possible link between social class and coronary heart disease. BMJ 1985; 291: 1312-14.
9. Baker IA, Sweetnam PM, Yarnell JWG, Bainton D, Elwood PC. Haemostatic and other risk factors for ischaemic heart disease and social class: evidence from the Caerphilly and Speedwell studies. Int J Epidemiol 1988; 17: 759-65.
10. Marmot MG, Rose G, Shipley M, Hamilton PJS. Employment grade and coronary heart disease in British civil servants. J Epidemiol Community Health 1978; 32: 244-49.
11. Davey Smith G, Shipley MJ, Rose G. Magnitude and causes of socioeconomic differentials in mortality: further evidence from the Whitehall Study. J Epidemiol Community Health 1990; 44: 265-70.
12. Hein HO, Suadicani P, Gyntelberg F. Ischaemic heart disease incidence by social class and form of smoking: the Copenhagen male study - 17 years' follow-up. J Intern Med 1992; 231: 477-83.
13. Rosengren A, Wilhemsen L, Welin L, Tsipogianni A, Teger-Nilsson A, Wedel H. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. BMJ 1990; 300: 634-38.
14. Brunner EJ, Marmot MG, White IR, et al. Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II study. Atherosclerosis 1993; 102: 195-207.
15. Marmot MG, Davey Smith G, Stansfeld S, et al. Health inequalities among British civil servants: the Whitehall II study. Lancet 1991; 337: 1387-93.
16. Karasek R, Baker D, Marxer F, Ahlbom A, Theorell T. Job decision latitude, job demands and cardiovascular disease: a prospective study of Swedish men. Am J Public Health 1981; 71: 694-705.
17. Marmot MG, Feeney A, Shipley M, North F, Syme SL. Sickness absence as a measure of health status and functioning: from the UK Whitehall II Study. J Epidemiol Community Health 1995; 49: 124-30.
18. Wilson TW, Kaplan GA, Kauhanen J, et al. Association between plasma fibrinogen concentration and five socioeconomic indices in the Kuopio ischaemic heart disease risk factor study. Am J Epidemiol 1993; 137: 292-300.
19. Eliasson M, Evrin P-E, Lundblad D. Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure: the northern Sweden MONICA study. J Clin Epidemiol 1994; 47: 513-24.
20. Meade TW. Epidemiology of atheroma, thrombosis and ischaemic heart disease. In: Bloom AL, Thomas DP, eds. Haemostasis and thrombosis, 2nd ed. Edinburgh: Churchill Livingstone, 1987: 697-720.
21. Rabbani LE, Loscalzo J. Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque. Atherosclerosis 1994; 105: 1-7.
22. Patel P, Mendall MA, Carrington D, et al. Assocation of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-14.
23. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
24. Juhan-Vague I, Thompson SJ, Jespersen J. Involvement of the hemostatic system in the insulin resistance syndrome. Arterioscler Thromb 1993; 13: 1865-73.
25. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 191: 205.
26. Eschwege E, Richard JL, Thibault N, et al. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris Prospective Study, ten years later. Horm Metab Res 1985; 15 (suppl): 41-46.
27. Ferrara A, Barrett-Connor EL, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo study, 1984-1991. Am J Epidemiol 1994; 140: 857-69.
28. Lee AJ, Smith WCS, Lowe GDO, Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J Clin Epidemiol 1990; 43: 913-19.
29. Folsom AR, Qamhieh HT, Flack JM, et al. Plasma fibrinogen: levels and correlates in younger adults. Am J Epidemiol 1993; 138: 1023-36.
30. Marmot MG, Brunner EJ. Alcohol and cardiovascular disease: the status of the U-shaped curve. BMJ 1991; 303: 565-68.
31. Peck MN, Lundberg O. Short stature as an effect of economic and social conditions in childhood. Soc Sci Med 1995; 41: 733-38.
32. Barker DJP, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986; i: 1077-81.
33. Davey Smith G, Ben Shlomo Y. Early growth and clotting factors in adult life. BMJ 1992; 304: 638.
34. Bartley M, Power C, Blane D, Davey Smith G, Shipley M. Birth weight and later socioeconomic disadvantage: evidence from the 1959 British cohort study. BMJ 1994; 309: 1475-79.
35. Alterman T, Shekelle RB, Vernon SW, Burau KD. Decision latitude, psychologic demand, job strain, and coronary heart disease in the Western Electric study. Am J Epidemiol 1994; 139: 620-27.
36. Bullers S. Women's roles and health: the mediating effect of perceived control. Women & Health 1994; 22: 11-30.